標題：Anti-Hendra virus/HeV Glycoprotein G Monoclonal Antibody (1A207)抗體,AntibodySystem Laboratories

鏈接：https://www.antibodysystem.com/product/20586.html

名稱：Anti-Hendra virus/HeV Glycoprotein G Monoclonal Antibody (1A207)抗體

別名：Glycoprotein G, G, Hendra virus (isolate Horse/Autralia/Hendra/1994) (HeV)

貨號：MVV08003

適用物種：Hendra virus (isolate Horse/Autralia/Hendra/1994) (HeV)

宿主：Mouse

形式：Liquid

純度：>95%

同種型：IgG1

應用：ELISA, WB

純化：Protein G purified from mice ascites.

UniProt：O89343

用途范圍：僅用于科研

儲存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

產(chǎn)品購買聯(lián)系方式：027-65279366 /18162686757

郵箱：biolab-reagents@atagenix.com

QQ：2663991332

參考文獻：

Architecture and antigenicity of the Nipah virus attachment glycoprotein. PMID: 35239409
Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant. PMID: 35617431
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses. PMID: 37243163
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PMID: 24130486
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. PMID: 31570878
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein. PMID: 36932063
Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody. PMID: 36816187
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. PMID: 31686101
Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody. PMID: 30995971
Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. PMID: 17376907
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. PMID: 18799571
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. PMID: 33927387
Prefusion stabilization of the Hendra and Langya virus F proteins. PMID: 38214525
Structure and design of Langya virus glycoprotein antigens. PMID: 38593070
Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus. PMID: 16186240
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. PMID: 19216624
Vaccines to Emerging Viruses: Nipah and Hendra. PMID: 32991264
Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. PMID: 16378991
Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model. PMID: 16840334
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. PMID: 38569014
Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. PMID: 18271743
Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. PMID: 18054977
Prediction of the binding interface between monoclonal antibody m102.4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking. PMID: 33106487
Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems. PMID: 17292974
Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. PMID: 22915804